DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Kopetz S, McDonough S, Van Karlyle M. et al.
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406).
ASCO GI 2017 Abstr. #520
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.